We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

140 hedge funds and large institutions have $146M invested in Bionano Genomics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 44 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $6.56M | Put options by funds: $2.96M

29% more capital invested

Capital invested by funds: $114M → $146M (+$32.9M)

0% less ownership

Funds ownership: 0.05% → 0.05% (-0%)

2% less funds holding

Funds holding: 143 → 140 (-3)

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

23% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 44

Holders
140
Holders Change
-3
Holders Change %
-2.1%
% of All Funds
2.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
34
Reduced
44
Closed
20
Calls
$6.56M
Puts
$2.96M
Net Calls
+$3.6M
Net Calls Change
+$2.37M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$2.35M
2
BlackRock
BlackRock
New York
+$1.31M
3
Morgan Stanley
Morgan Stanley
New York
+$690K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$589K
5
Goldman Sachs
Goldman Sachs
New York
+$342K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$4.95M
2
Citadel Advisors
Citadel Advisors
Florida
-$1.77M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$1.7M
4
Bank Julius Baer & Co
Bank Julius Baer & Co
Switzerland
-$1.42M
5
Two Sigma Investments
Two Sigma Investments
New York
-$712K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cetera Investment Advisers
101
Cetera Investment Advisers
Illinois
$25K -$2.64K -2 -8%
SAM
102
Shell Asset Management
Netherlands
$24K -$2.64K -2 -8%
CFGS
103
Concourse Financial Group Securities
Alabama
$24K – – –
MFG
104
Magnus Financial Group
New York
$23K – – –
BMC
105
Benin Management Corp
Connecticut
$22K – – –
CIBC Asset Management
106
CIBC Asset Management
Ontario, Canada
$22K – – –
KeyBank National Association
107
KeyBank National Association
Ohio
$22K – – –
AWA
108
Arete Wealth Advisors
Illinois
$21K +$25.1K +19 New
OMC
109
Old Mission Capital
Illinois
$21K +$25.1K +19 New
PAG
110
Private Advisor Group
New Jersey
$20K -$2.64K -2 -10%
MFG
111
Merit Financial Group
Georgia
$20K – – –
CAM
112
Carret Asset Management
New York
$18K – – –
Credit Agricole
113
Credit Agricole
France
$18K – – –
KAM
114
Knightsbridge Asset Management
California
$18K +$22.5K +17 New
RG
115
Retirement Group
California
$15K +$17.2K +13 New
CG
116
Cutler Group
California
$12K -$5.29K -4 -27%
Royal Bank of Canada
117
Royal Bank of Canada
Ontario, Canada
$11K +$5.29K +4 +67%
Wells Fargo
118
Wells Fargo
California
$9K -$11.9K -9 -50%
TWC
119
TD Waterhouse Canada
Ontario, Canada
$8.2K – – –
Rockefeller Capital Management
120
Rockefeller Capital Management
New York
$7K +$9.25K +7 New
APA
121
American Portfolios Advisors
New York
$5.36K – – –
UBS Group
122
UBS Group
Switzerland
$4K -$108K -82 -95%
US Bancorp
123
US Bancorp
Minnesota
$4K -$5.29K -4 -50%
AWM
124
AllSquare Wealth Management
New York
$4K – – –
SWM
125
Spire Wealth Management
Virginia
$3K -$141K -107 -97%
3 4
5
6 7

BNGO Hedge Fund Activity: Q3 2022 in Review

140 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q3 2022, worth a combined $146M — up 29% from $114M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of BNGO and 17 opened new positions — a net loss of 3 holders — while 44 trimmed existing stakes and 34 added.

The largest buyer was State Street, adding an estimated $2.35M. The largest seller was Renaissance Technologies, cutting an estimated $4.95M.

  • 140 institutional investors held Bionano Genomics (BNGO) as of Q3 2022, down from 143 in Q2 2022.
  • Funds reported $146M of Bionano Genomics stock for Q3 2022, up 29% quarter-over-quarter.
  • 17 funds opened new Bionano Genomics positions in Q3 2022 and 20 closed out, a net change of -3 holders.
  • The largest Bionano Genomics buyer in Q3 2022 was State Street, an estimated $2.35M added.
  • The largest Bionano Genomics seller in Q3 2022 was Renaissance Technologies, an estimated $4.95M sold.

Based on aggregated 13F filings for Q3 2022.